Author
Listed:
- Javier Martín-Escolano
- Ana Ruiz-Molina
- Cristina Rodríguez-Urbistondo
- Carmen Infante-Domínguez
- Gabriela Abelenda-Alonso
- Gorane Euba
- Zaira R Palacios-Baena
- Francisco Arnaiz-Revillas
- Jorge Alba
- Alexander Rombauts
- Regino J Rodríguez-Álvarez
- Natalia Maldonado
- Claudia González-Rico
- Sonia Santibañez
- Marta Carretero-Ledesma
- Laura Merino
- Jordi Carratalá
- Ane Josune Goikoetxea-Agirre
- Marta Fernández-Martínez
- José Antonio Oteo
- María Carmen Fariñas
- Jesús Rodríguez-Baño
- José Miguel Cisneros
- Belén Gutiérrez-Gutiérrez
- Rocío Álvarez-Marín
- Manuela Aguilar-Guisado
- Sonsoles Salto-Alejandre
- Elisa Cordero
- Jerónimo Pachón
- Javier Sánchez-Céspedes
Abstract
Objectives: SARS-CoV-2 RNAemia at diagnosis is associated with mortality. The aims were to identify factors associated with the development of RNAemia. Methods: Multicenter COVID-19 cohort study was conducted between January 2020 and May 2023. Demographics, chronic underlying diseases, symptoms and signs, analytical and radiological variables, cytokines, and neutralizing antibodies were evaluated on admission. RNAemia was the primary endpoint. Results: We included 1011 patients, 392 (38.8%) immunocompromised and 619 (61.2%) immunocompetent. RNAemia occurred in 49.7% and 18.7% (p 300 UI/L (OR: 1.64 [1.02–2.63]) and neutralizing antibodies absence (OR: 2.51 [1.57–4.00]). In immunocompetent patients, the factors associated with RNAemia were Delta and Omicron VOC periods (OR: 2.27 [1.46–3.52]), lymphocyte count 300 IU/L (OR: 3.99 [2.51–6.36]). Conclusions: Immunodeficiency almost tripled SARS-CoV-2 RNAemia. Omicron VOC period, LDH as inflammatory biomarker, and a lower immune response in all patients, neutralizing antibodies absence in immunocompromised and lymphopenia in immunocompetent, and pneumonia in immunocompromised patients were associated with RNAemia.
Suggested Citation
Javier Martín-Escolano & Ana Ruiz-Molina & Cristina Rodríguez-Urbistondo & Carmen Infante-Domínguez & Gabriela Abelenda-Alonso & Gorane Euba & Zaira R Palacios-Baena & Francisco Arnaiz-Revillas & Jorg, 2025.
"Factors associated with SARS-CoV-2 RNAemia development at COVID-19 diagnosis,"
PLOS ONE, Public Library of Science, vol. 20(8), pages 1-14, August.
Handle:
RePEc:plo:pone00:0330495
DOI: 10.1371/journal.pone.0330495
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0330495. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.